In the news

Through interviews with senior executives and industry analysts, The Boston Globe explores how the combination of Boston Scientific’s acquisition strategy, in-house R&D and investment portfolio position the company for long-term success.

Boston Scientific has completed its $1.18 billion acquisition of Silk Road Medical, adding the TCAR stroke-prevention platform to its vascular portfolio to enhance patient outcomes and expand its minimally invasive treatment options.

Dr. Ken Stein, senior vice president and global chief medical officer, illustrates AI’s potential to enable more personalized care, especially through wearable devices and home-based health monitoring.

Camille Chang Gilmore, vice president of human resources and global chief diversity officer, shares our commitment to developing a workforce that is reflective of the patients and communities we serve, inclusive of individuals with disabilities.

Samir Bhattacharyya, vice president of global value and marketing for Health Economics & Market Access, Urology, discusses the impact erectile dysfunction (ED) can have on work productivity and mental health and the importance of ensuring ED treatment coverage is available to employees.